Dopamine and 5-HT receptor sensitivity does not correlate with neostriatal dopamine or 5-HT content

被引:0
|
作者
Kostrzewa, RM
Brus, R
Perry, KW
Fuller, RW
机构
[1] L WARYNSKI SILESIAN MED ACAD,DEPT PHARMACOL,PL-41808 ZABRZE,POLAND
[2] ELI LILLY & CO,LILLY RES LABS,INDIANAPOLIS,IN 46285
关键词
dopamine; dopamine receptors; neostriatum; oral dyskinesias; receptor supersensitivity; serotonin; 5-HT receptors; 6-hydroxydopamine;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
To explore associations of neostriatal (NST) endogenous levels of dopamine (DA) and serotonin (5-HT) with sensitivity of their receptors, graded doses of 6-hydroxydopamine HBr (0 to 400 mu g, ICV; 6-OHDA; desipramine pretreatment, 20 mg/kg IP) were given to rats' between birth (P 0) and P 42. Numbers of vacuous chewing movements (VCMs) induced by SKF 38393 or m-chlorophenylpiperazine (m-CPP), respective DA D-1 and 5-HT2 agonists, were subsequently determined. Enhanced SKF 38393-induced VCMs occurred when NST DA was reduced 97%-98% by high dose 6-OHDA (100-134 mu g) at P 0 or P 3, but not in rats with 95%-97% loss in DA produced by 6-OHDA at P7 (134 mu g) or P3 (67 mu g). Enhanced m-CPP-induced VCMs occurred even when NST 5-HT content was not elevated after 6-OHDA (134 mu g at P 10). Accordingly, D-1 and 5-HT receptor sensitivity is not correlated with respective NST DA and 5-HT contents. The stage of ontogeny at the time of DA denervation may be the governing influence on receptor sensitivity.
引用
收藏
页码:21 / 28
页数:8
相关论文
共 50 条
  • [41] Pharmacological Evidence for 5-HT6 Receptor Modulation of 5-HT Neuron Firing in Vivo
    Brouard, Julia T.
    Schweimer, Judith V.
    Houlton, Rachel
    Burnham, Katherine E.
    Queree, Philip
    Sharp, Trevor
    ACS CHEMICAL NEUROSCIENCE, 2015, 6 (07): : 1241 - 1247
  • [42] The role of 5-HT receptors in depression
    Yohn, Christine N.
    Gergues, Mark M.
    Samuels, Benjamin Adam
    MOLECULAR BRAIN, 2017, 10
  • [43] Are 5-HT Levels Increased in Depression?
    Dias, Alvaro Machado
    CURRENT PSYCHIATRY REVIEWS, 2011, 7 (01) : 19 - 24
  • [44] The role of 5-HT receptors in depression
    Christine N. Yohn
    Mark M. Gergues
    Benjamin Adam Samuels
    Molecular Brain, 10
  • [45] Paroxetine as a 5-HT neuroendocrine probe
    H. Kojima
    T. Terao
    M. Iwakawa
    A. Soya
    N. Inoue
    Y. Shiraishi
    Y. Son
    S. Soeda
    N. Ueda
    R. Yoshimura
    J. Nakamura
    Psychopharmacology, 2003, 167 : 97 - 102
  • [46] Depletion of 5-HT Disrupts Prepulse Inhibition in Rats: Dependence on the Magnitude of Depletion, and Reversal by a 5-HT Precursor
    Eric PM Prinssen
    Marie-Bernadette Assié
    Wouter Koek
    Mark S Kleven
    Neuropsychopharmacology, 2002, 26 : 340 - 347
  • [47] Forced swimming test and fluoxetine treatment: in vivo evidence that peripheral 5-HT in rat platelet-rich plasma mirrors cerebral extracellular 5-HT levels, whilst 5-HT in isolated platelets mirrors neuronal 5-HT changes
    Bianchi, M
    Moser, C
    Lazzarini, C
    Vecchiato, E
    Crespi, F
    EXPERIMENTAL BRAIN RESEARCH, 2002, 143 (02) : 191 - 197
  • [48] Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in Parkinsonian rats
    Carta, Manolo
    Carlsson, Thomas
    Kirik, Deniz
    Bjorklund, Anders
    BRAIN, 2007, 130 : 1819 - 1833
  • [49] The effect of central noradrenergic system lesion on dopamine (DA) and serotonin (5-HT) synthesis rate following administration of 5-HT3 receptor ligands in chosen parts of the rat brain
    Roczniak, Wojciech
    Babuska-Roczniak, Magdalena
    Kwapulinski, Jerzy
    Brodziak-Dopierala, Barbara
    Widuchowski, Wojciech
    Cipora, Elzbieta
    Nowak, Przemyslaw
    Oswiecimska, Joanna M.
    PHARMACOLOGICAL REPORTS, 2015, 67 (01) : 146 - 151
  • [50] The effect of central noradrenergic system lesion on dopamine (DA) and serotonin (5-HT) synthesis rate following administration of 5-HT3 receptor ligands in chosen parts of the rat brain
    Wojciech Roczniak
    Magdalena Babuśka-Roczniak
    Jerzy Kwapuliński
    Barbara Brodziak-Dopierała
    Wojciech Widuchowski
    Elżbieta Cipora
    Przemysław Nowak
    Joanna M. Oświęcimska
    Pharmacological Reports, 2015, 67 : 146 - 151